Aligos Therapeutics (ALGS) delivered earnings and revenue surprises of +34.89% and -3.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today ...

Razer is offering players a chance to get their hands on Battlefield 6 early access codes. The official Razer social pages ...

The Assault class is the frontline segment. They are responsible for pushing through enemy defenses using some of the most ...

Apex Legends map Broken Moon will not appear in ALGS for 2025 after the Pro League Qualifiers, according to the official ...

Eric Wrona aka Snip3down is one of the most DEDICATED gamers in the world! Watch Snip3down & TSM in the ALGS Championship ...

Reports Q2 revenue $965,000, consensus $433,330. “Initiation of the Phase 2 B-SUPREME study of ALG-000184 is well underway with regulatory ...

The latest Apex Legends patch changes Caustic and Bangalore ahead of Season 26: Showdown, impacting the casual and esports ...

Learn about the executive team and board of directors at Aligos Therapeutics Inc Ordinary Shares (ALGS:XNAS) and review their bios and compensation over the latest fiscal years.

Apex Legends Season 26 looks to shake things up in the battle royale, teasing ranked changes, weapon reworks, and a whole new ...

The 25th season of Apex Legends has been a futuristic blast, but each season can only last for so long. This August, Respawn is preparing to launch yet another ...